These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17687076)

  • 1. Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice.
    Ka SM; Sytwu HK; Chang DM; Hsieh SL; Tsai PY; Chen A
    J Am Soc Nephrol; 2007 Sep; 18(9):2473-85. PubMed ID: 17687076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoy receptor 3 inhibits renal mononuclear leukocyte infiltration and apoptosis and prevents progression of IgA nephropathy in mice.
    Ka SM; Hsieh TT; Lin SH; Yang SS; Wu CC; Sytwu HK; Chen A
    Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1218-30. PubMed ID: 21900455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice.
    Ka SM; Huang XR; Lan HY; Tsai PY; Yang SM; Shui HA; Chen A
    J Am Soc Nephrol; 2007 Jun; 18(6):1777-88. PubMed ID: 17475816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoy receptor 3 attenuates collagen-induced arthritis by modulating T cell activation and B cell expansion.
    Cheng CP; Sytwu HK; Chang DM
    J Rheumatol; 2011 Dec; 38(12):2522-35. PubMed ID: 21885501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoy receptor 3 ameliorates experimental autoimmune encephalomyelitis by directly counteracting local inflammation and downregulating Th17 cells.
    Chen SJ; Wang YL; Kao JH; Wu SF; Lo WT; Wu CC; Tao PL; Wang CC; Chang DM; Sytwu HK
    Mol Immunol; 2009 Dec; 47(2-3):567-74. PubMed ID: 19819554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
    Phoon RK; Kitching AR; Jones LK; Holdsworth SR
    Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.
    Han B; Moore PA; Wu J; Luo H
    Arthritis Rheum; 2007 Nov; 56(11):3748-58. PubMed ID: 17968950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
    Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
    Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.
    Mueller AM; Pedré X; Killian S; David M; Steinbrecher A
    J Neuroimmunol; 2009 Apr; 209(1-2):57-64. PubMed ID: 19269042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus.
    Han B; Bojalil R; Amezcua-Guerra LM; Springall R; Valderrama-Carvajal H; Wu J; Luo H
    Int Immunol; 2008 Aug; 20(8):1067-75. PubMed ID: 18562337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
    Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis.
    Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
    J Am Soc Nephrol; 2007 Mar; 18(3):760-70. PubMed ID: 17267745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern recognition and renal defence in crescentic glomerulonephritis.
    Berger SP; Daha MR
    Nephrol Dial Transplant; 2010 Sep; 25(9):2876-8. PubMed ID: 20650906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells in crescentic glomerulonephritis.
    Tipping PG; Holdsworth SR
    J Am Soc Nephrol; 2006 May; 17(5):1253-63. PubMed ID: 16624930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
    Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2Y1 gene deficiency protects from renal disease progression and capillary rarefaction during passive crescentic glomerulonephritis.
    Hohenstein B; Renk S; Lang K; Daniel C; Freund M; Léon C; Amann KU; Gachet C; Hugo CP
    J Am Soc Nephrol; 2007 Feb; 18(2):494-505. PubMed ID: 17215444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats.
    Yamahana J; Wada T; Furuichi K; Sakai N; Yokoyama H; Kaneko S
    Nephrol Dial Transplant; 2006 Oct; 21(10):2736-44. PubMed ID: 16891648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
    Lin WW; Hsieh SL
    Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crescentic glomerulonephritis in interferon-gamma receptor deficient mice.
    Haas C; Ryffel B; Le Hir M
    J Inflamm; 1995-1996; 47(4):206-13. PubMed ID: 9144077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.